EPCAM and breast carcinoma: In a direct comparison, more CTCs in breast cancer metastases were identified with CellSearch® than with ISET® (21), likely because of the passage of smaller cells with reduced EpCAM expression through the pores of ISET® membranes (61) or the absence of small cells stained in spots for CTC counting, as described in the Methods section.